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Introduction
’Incorrect test results are much more often due to patient
and specimen collection considerations than to labora-
tory variability or error’ [1], according to one USA based
professional organization. Shapiro [2] noted in a study
involving thousands of patients, more than 5% of the
individually collected specimens were questionable based
on pre-analytical error, and, indeed, more than 15% of
the specimens received from the emergency room were
associated with significant pre-analytical error! Since
’blood gas and pH analysis has more immediacy and
potential impact on patient care than any other labora-
tory determination’ [3], it is evident that while the
medical laboratory analyst must be primarily aware of
the impact of analytical error, pre-analytical consider-
ations need to be taken into account by others in the
assessment of the reliability of results to be reported. An
understanding by physicians, nurses and other direct
patient care practitioners of the ’Cycle of quality
assurance’ (see figure) for blood gases and other critical
analytes will minimize the chances that pre-analytical
error will significantly effect patient care. The laboratory
professional must be involved in the process ofeducation
about these issues.
Pre-analytical considerations
Of major impact on the utility of blood gas, total
haemoglobin and electrolyte results are (1) the physio-
logic stability of the patient; (2) the effects of blood
metabolism and collection/transport conditions on the
analytes measured; and (3) the timeliness ofthe collection
and reporting of results.
A comprehensive review ofvarious pre-analytical aspects
of blood gas analysis is given in a document prepared by
the USA-based National Committee for Clinical
Laboratory Standards (NCCLS) [3]. This article concen-
trates on certain key points of that document, as well as
providing some more recent additional information.
Physiologic stability
The ventilatory process is a key consideration affecting
blood gas values. Patient postural changes affect ventila-
tory rate and depth, thus causing real changes in blood
gas values, especially in the Pco2(aB), but also in the
po2(aB). Circulatory compromise, such as that seen in
arrested patients during resuscitative efforts, can cause
samples from peripheral collection sites to be non-
representative of whole body conditions. The effects of
these types ofconditions could either be recognized by the
clinician or the changed results assumed to be ’labora-
tory’ error, thus masking a need for intervention, or
bringing about inappropriate intervention. Patients on
controlled ventilation, or supplemental oxygen, ideally
should be assessed only after new settings have been in
effect for at least 20 min. In other cases, especially when
’weaning’ a patient from mechanical ventilation (PEEP,
CPAP, IMV) or supplemental oxygen, a result may be
urgently required between 5 and 10 min after each
change.
Collection and transport conditions
The collection process itself, being potentially painful,
may bring on an apprehensive hyperventilation by the
patient, causing an immediate effect on Pco(aB),
lowering the value.
Collection devices are also subject to limitation. The ideal
system incorporates a collection device (syringe) that
minimizes or eliminates exposure to air, includes the
correct extent ofheparin anticoagulation (20-50 U/ml of
blood) and enables identification of the collection site as
being arterial (by responsiveness to arterial pressure). If
subsequent or simultaneous measurement of sodium,
potassium or ionized calcium on the same sample is
anticipated, the effects ofthe anticoagulant must be taken
into account. (For example the use ofsodium heparinate
will normally elevate the measured sodium by 1-3 mmol/
1, or even more ifthe syringe is not completely filled. Also,
the binding effects of heparin on ionized calcium can
lower the sample’s ionized calcium significantly if the
heparin dose is >20 U/ml of blood.)
One of the more significant sources ofunrecognized error
in the Pco2 measurement is the use of too great a volume
(as opposed to units) of liquid heparin relative to the
amount of blood collected (underfilling a syringe), which
leads to a falsely low value. The pH may also be lowered,
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but only when the underfilling is severe. Use ofa low-dose
dried lithium heparin anticoagulant or a ’calcium
balanced’, or ’titrated’, heparin should eliminate these
problems.
Exposure of the sample to air has the obvious effects on
both Po2 and Pco2 due to potential differences in the
tensions of the gases in air versus the sample. An
unrecognized cause of error is the common practice of
’flicking’ the syringe to rid it of air bubbles prior to
measurement, since this excessive agitation can cause
formation of tiny air bubbles which will equilibrate with
the sample more readily than a large bubble. This will
typically lower Pco2 and elevate Po2 values; however, if
the patient is breathing high concentrations ofoxygen, air
contamination may cause a lowering ofpo values.
The use of ’arterialized’ capillary blood for the measure-
ment ofpo should be recognized as a last resort only.
While acceptable for pH and Pco, the results are a
reliable estimate ofarterial values only at oxygen tensions
less than 8"0 kPa (60 mmHg). Above that level, the
opposing effects of tissue metabolism and air contamina-
tion during collection create a large potential uncertainty
in results at oxygen tensions where accuracy and
precision are paramount. (For example at or near 13"0
kPa [approximately 100 mmHg], the point at which
oxygen therapy levels are most critical in neonates.)
Vacuum tubes are suitable collection devices only for
venous blood and acid base/electrolyte measurement,
since, because of the vacuum, they aspirate blood from
any vessel, and thus reduces the ability to assess
placement of the needle in an artery. The gas bubble in
the tube can change sample results (lower Pco and
elevatepo). Ifa vacuum tube is used the report should be
labelled as to source, and the appropriate symbol used
[for example pH(vB), Pco(vB)].
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Due to frequency of multiple blood gas analyses on the
same patient over short time intervals, recording of the
exact collection time on each specimen is necessary. If
more than one specimen on the same patient is in the
blood gas laboratory simultaneously without the collec-
tion time or sequence being labelled, the results should be
held from reporting until the issue is resolved.
The immediate impact that blood gas results can have on
clinical management and decisions affecting morbidity
and mortality emphasizes the need for strict adherence to
proper identification of the patient, patient conditions
and the sample while at the same time treating the sample
as quickly as possible.
Metabolic effects
Once collected, the specimen should be analysed in a few
minutes (less than 10) or placed in an ice-water slurry.
(Use of crushed ice alone will cause uneven cooling and
artificial coolants may cause freezing of portions of the
blood sample.) The effect of this slurry is to reduce
cellular metabolism which in turn minimizes the utiliza-
tion of oxygen and production of carbon dioxide by this
’living tissue’ sample. A combination of immediate icing
and analysis as soon as possible may be required with
known severe leucocytosis (leukaemia) or reticulocytosis,
or with severe sepsis, since the increased numbers of
metabolically active cells can cause rapid changes in the
gases, especially oxygen.
If simultaneous or subsequent analysis of potassium on
the same sample is anticipated, the analysis should occur
within 30 min ofcollection and placement in the ice-water
slurry. Potassium values on samples kept in an ice-water
slurry for longer times may be elevated by 0"2 mmol/1 or
greater [6]. Some data indicates that samples from
patients with cold agglutinins may be substantially
elevated after only a few (<15) minutes in the ice-water
slurry [7]. Both of these findings were observed when no
visible haemolysis was present.
Turnaround time
While post-collection intervals as long as two hours may
not invalidate the measurement ofpH, Po2 and Pco2 in a
properly iced sample, most clinical needs are for a much
shorter duration (15 to 30 min turnaround time) [8].
Analyser maintenance
For consistently reliable results, it is important that all
routine maintenance be carried out in the manner and
frequency specified by the manufacturer. While changes
in maintenance may not affect results immediately,
substantial changes in practice will, over time, alter
performance. Changes in performance may also result if
reagents and solutions other than those specified by the
manufacturer are used. Again, the changes may be subtle
and may take a long time to become obvious. The end
result, however, will be the failure of the analyser to
perform as reliably as it is capable of doing.
Analysis
When introducing the sample to the analyser, it is
essential to carefully read and follow the instructions for
the particular instrument. Each analyser’s sample-
handling protocol may be different, and differences in
technique on the same analyser may affect results.
Complete mixing of the sample prior to analysis, by a
combination of rolling and inversion of the sample
container, is important to ensure satisfactory results in
the measurement ofpH, Pco andPo, and it is critical if
the measurement of total haemoglobin (tHb) or packed
cell volume (pcv or Hct) is to be performed.
Reporting results
After analysis, results for each analyte should be com-
pared with the history, patient temperature, past results,
ventilatory/supplemental oxygen conditions at the time
of collection, and with prior ’blood gas’ values on the
same patient to see if they are compatible. An excellent
check for within-sample result consistency is application
of the modified ’alveolar air equation’:
Po2(A)* FIO2[Patm Primo] l’25[Pco(aB)] (1)
* (A) refers to alveolar gas.
By substitution of the fraction ofinspired oxygen (FIO2),
the atmospheric pressure (Patm), the water vapour
pressure PI4O) and the measured Pco2(aB), the alveolar
partial pressure of oxygen can be estimated and com-
pared with the arterial value as measured. Given the
expected difference between alveolar and arterial Po,
[A-aDO], an assessment of ’mistakes’ in the measure-
ment can be made before reporting the results. The
minimum criterion is that the A-aDO be >0, although
typically it is 0"7-2 kPa.
The usual precautions hold true in reporting blood gas
results by whatever means (verbal, written or automatic)
but again, as with the patient and specimen identifica-
tion, the immediate and critical impact of the blood gas
results serves to emphasize that no exceptions to standard
protocol can be tolerated.
Temperature ’correction’ of blood gas values
The values for pH and gas tensions unquestionably vary
with respect to temperature. As a result, many labora-
tories report blood gas values ’corrected or adjusted’ to
the temperature of the patient.
While some clinicians may have practical experience and
’know’ what to expect at temperatures other than 37 C,
there are no widely accepted reference values at different
temperatures. Next, is the issue of what to do with the
’adjusted’ values obtained. For example, does one try to
regulate the patient’s pH and Pco2 to 7"40 and 5.33 kPa
(40 mmHg) respectively? Finally, what algorithms does
one choose to use to make the adjustment from 37C to
the patient’s temperature?
From the perspective ofthe blood gas laboratory, the first
two issues are most reasonably addressed by accepting
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the recommendations ofAshwood et al. [9]. For the acid-
base values (pH and Pco2) and calculated quantities,
such as actual bicarbonate, report values at the measur-
ing temperature of 37C. For Pco2 and Po, used in
assessing gas exchange and possibly compared with
expired gases, report temperature ’adjusted’ values. On a
practical basis, this means that the carbon dioxide
tension and oxygen tension values should be reported at
both temperatures, while pH should be reported only for
37 C. The report itselfshould clearly distinguish between
the values at the two temperatures.
The last issue is easiest to address, since, for most blood
gas laboratories, the algorithm used is that chosen by the
manufacturer of the analyser. NCCLS document C-12T2
[4], a frame of reference accepted by many, states that its
standard is met if the algorithm used to make the
’correction’ gives results that are quantitatively similar to
those specifically documented in the standard.
Algorithms chosen by the three major blood gas manufac-
turers meet those criteria.
Assessment of measuring system performance:
quality control
A properly maintained blood gas analyser, calibrated
either with buffer and gases prepared by the manufac-
turer or traceable to them 10], will give years of reliable
service.
As noted earlier, many or even most blood gas result
’errors’ occur outside the area of laboratory analysis [1,
2]. Additionally, many modern blood gas analysers
incorporate automatic devices which signal when the
analyser is not performing adequately.
Despite these facts, there is an increasing level of activity
in the use ofinternal and external quality control schemes
to check on analyser performance. Quality control
schemes, of course, only check on performance of the
analyser on the test material actually chosen, and at the
time the control material is actually measured. As such,
any such quality control scheme needs to be considered as
only a part of a complete programme that addresses the
various issues discussed in this report. The requirements
and complications ofquality control protocols for a blood
gas analyser are substantially different from other
analyses performed in the clinical laboratory environ-
ment. This is due substantially to the combination of
turnaround time requirements for the patient sample, the
fact that the patient sample is fresh whole blood--that
is--living tissue, and ofcourse, the various pre-analytical
items discussed earlier in this report.
The optimum technique for establishing the inaccuracy
and imprecision ofthe gas channels ofan individual blood
gas analyser is the use ofwhole blood tonometry [11, 12],
using fresh anticoagulated whole blood, carefully equili-
brated with a known standard mixture ofoxygen, carbon
dioxide and nitrogen at 37C. Properly done, this
technique enables determination of the performance of
the analyser when measuring blood at the partial
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pressures of the tonometry gas mixtures. In essence,
tonometry more closely resembles a primary standard in
a true sample matrix, not merely a control material. The
technical and economic advantages of whole blood
tonometry must be balanced by hazard potential and the
labour-intensive nature of the process.
The alternative to whole blood tonometry is the use of
commercially available pre-packaged materials, each
type having its own ’mix’ of advantages. There are
currently three major types of commercially available
controls used for blood gas quality control each ofwhich
is gas-equilibrated; aqueous buffer solutions, blood-based
(haemoglobin-containing) materials, and perfluoro-
carbon/oil emulsions. Their effectiveness varies and is
dependent on the particular analyte and the physical and
chemical characteristics of the material itself. While, for
blood gases alone, one might consider the purported
marginal advantages ofnon-aqueous materials, the fact is
that aqueous buffers are economical and acceptable for
routine performance assessment of pH and blood gas.
However, if electrolytes are also to be measured on the
same analyser as the blood gas, it is probably most
feasible to use the aqueous-based materials, since ac-
ceptable values for the electrolytes are also available.
While not as good as whole blood (patient) duplicates
run on separate analysers offer the best combination of
economy, feasibility and analytical quality.
The fundamental issue with respect to any non-blood
control is that their physical and chemical properties do
not, in many respects, match those of whole blood. As a
result, they may not detect certain problems or they may
signal problems that are not there. The former situation
can result in clinical problems; the latter creates financial
issues due to the cost of repeat controls, labour, and
possibly, unnecessary service calls.
Selection of a particular type of control must be based on
evaluation of its technical and other merits in the context
of a complete blood gas quality control programme. In
that context, the pre-packaged controls can serve a
primary role in assessing blood gas analyser performance,
while remembering that when a true performance issue
arises (with respect to the reliability of patient results),
only reference methods/materials may be able to settle it
satisfactorily 12].
Duplicate analysis of the same blood sample can be a
useful tool, but should not be used as the sole method for
assessing instrument performance. Duplicates measured
on two different analysers are most useful in detecting
individual sample errors due to the improbability of
similar errors occurring simultaneously on two different
instruments. Certain types of pH system malfunction
(reference circuit) can only be reliably detected using
whole blood. In an emergency situation, where analytical
reliability and turnaround time are equally important,
duplicate analysis ofthis type may be a requirement. Bear
in mind, however, that duplicate analysis on the same
instrument has a marginal usefulness at best, and at
worst, provides a false sense of security.R. F. Moran and A. Feuillu Critical care analytes
Descriptions of available blood gas control materials 12,
13] and detailed protocols for their use [3, 13] may assist
in choosing the quality control programme that meets the
requirement of the particular institution.
For those just beginning to consider a formal quality
control programme for blood gas or any other analyte, it
is best to assess the clinical requirements for result
quality, the analyser’s age and performance history, as
well as the control scheme and materials available. While
there is no substitute for quality, the extent needed for a
particular analyte group, such as blood gas, is not the
same in all institutions.
It is most important to start by reviewing all of the pre-
analytical issues discussed above with the medical staffof
the institution, at the same time determining their clinical
requirements. Once a quality assurance programme to
address the pre-analytical concerns has been established,
then a quality control program for the analyser, sufficient
to meet the clinical requirements, can be started.
Typically, this might begin by combining the use of (1)
daily duplicate analysis of several blood specimens
(preferably on two analysers), plus statistical comparison
of results; and (2) weekly or daily analysis of buffers of a
different lot number than that used to calibrate the
analyser. In either case, if results of analysis differ to an
unacceptable extent, corrective action must be taken and
the results recorded. The next step, after some experience
is gained with the above approach, might be to use a
single level (abnormal--either high or low) of commer-
cial pre-packaged control. This is used to test perfor-
mance after each change in reagents or electrodes. An
even better approach would be to use the control daily so
that normal performance can be compared with perfor-
mance after electrode or reagent changes.
In all cases, in developing a quality control programme,
keep records go that a real value to the quality control
scheme is clear. By observing values obtained, calculat-
ing mean values and standard deviation [13] and
comparing results with specific performance problems,
an overall scheme can be developed. If done in this
planned, stepwise manner, it will best meet the particular
institution’s requirements by balancing costs, time, and
quality.
Summary
As indicated at the outset ofthis article, the critical nature
of the clinical requirements when blood gas testing is
indicated, coupled with the labile nature of the sample
and rapidly changing patient conditions, makes it
imperative that the analyst be aware ofmore thanjust the
analysis itself. Knowledge by the analyst of the effects of
the changing patient environment, and the manner in
which the sample is treated in the few short minutes from
collection to reporting are equally important if one is to
assure timely and clinically meaningful results.
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